A testing procedure for survival data with few responders

被引：2

作者：

Freidlin, B ^{[1
]}

Korn, EL ^{[1
]}

机构：

[1] NCI, Biometr Res Branch, Bethesda, MD 20892 USA

来源：

STATISTICS IN MEDICINE | 2004年 / 23卷 / 11期

关键词：

D O I：

10.1002/sim.1660

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：1818 / 1823

页数：6

共 7 条

[1] Influence of unrecognized molecular heterogeneity on randomized clinical trials [J].

Betensky, RA ;

Louis, DN ;

Cairncross, JG .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) :2495-2499

[2] Targeting epidermal growth factor receptor - are we missing the mark? [J].

Dancey, JE ;

Freidlin, B .

LANCET, 2003, 362 (9377) :62-64

[3] Current status of HER2 testing [J].

Di Leo, A ;

Dowsett, M ;

Horten, B ;

Penault-Llorca, F .

ONCOLOGY, 2002, 63 :25-32

[4] A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES [J].

GEHAN, EA .

BIOMETRIKA, 1965, 52 :203-+

[5] ASYMPTOTICALLY EFFICIENT RANK INVARIANT TEST PROCEDURES [J].

PETO, R ;

PETO, J .

JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-GENERAL, 1972, 135 :185-&

[6] Improving the evaluation of new cancer treatments: challenges and opportunities [J].

Rothenberg, ML ;

Carbone, DR ;

Johnson, DH .

NATURE REVIEWS CANCER, 2003, 3 (04) :303-309

[7] Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. [J].

Slamon, DJ ;

Leyland-Jones, B ;

Shak, S ;

Fuchs, H ;

Paton, V ;

Bajamonde, A ;

Fleming, T ;

Eiermann, W ;

Wolter, J ;

Pegram, M ;

Baselga, J ;

Norton, L .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11) :783-792

← 1 →